SYK 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-07-31

• In the three months 2026 we achieved sales growth of 9.4% from

• margin of 25.2%, net earnings of $1,276 and net earnings per

• diluted share of $3.30. Excluding the impact of certain items,

• points to 27.4%, with adjusted net earnings(1) of $1,424 and

• adjusted net earnings per diluted share(1) of $3.69, an increase of

相对上期删除的文字 · 来源:10-Q · 2026-05-11

• organizational structure. Our new Ortho Tech business combines

• business with our Mako and enabling technologies portfolio from

• our Other Orthopaedics business. By bringing Mako, power tools,

• cutting accessories, enabling technologies and the teams behind

• these products together under one business, we are simplifying

相对上期新增的文字 · 来源:10-Q · 2026-07-31

• our Consolidated Financial Statements in our Annual Report on

• there can be no assurance that future events or developments

• will not cause such statements to be inaccurate. All forward-

• looking statements contained in this report are qualified in their

• entirety by this cautionary statement. We expressly disclaim any

相对上期删除的文字 · 来源:10-Q · 2026-05-11

• We are not aware of any material changes to the risk factors

• included in Item 1A. "Risk Factors" in our Annual Report on Form

• 10-K for 2025, except for updates to the following risk factors:

• addition, we rely on networks and services, including internet

• sites, cloud and software-as-a-service solutions, data hosting and

相对上期删除的文字 · 来源:10-Q · 2026-05-11

• On February 24, 2026 Spencer Stiles, our President and Chief

• Operating Officer, adopted a trading plan intended to satisfy the

• Exchange Act for the sale of shares of Stryker common stock.

• The plan terminates on the earlier of the close of trading on April

• to be sold under the plan is sold, subject to early termination for